Real-time colorimetric screening inhibitors of endonuclease with gold nanoparticle substrate
AssigneeNorthwestern University
InventorsChad A. Mirkin, Xiaoyang Xu, Min Su Han
Life of this patent
Estimating the term…
Loading patent…
AssigneeNorthwestern University
InventorsChad A. Mirkin, Xiaoyang Xu, Min Su Han
Estimating the term…
The invention provides methods for screening a compound for its effect on endonuclease activity. The methods comprise providing a compound to be screened utilizing a gold nanoparticle aggregate as the substrate for the endonuclease. The gold nanoparticle aggregate is formed by the hybridization of oligonucleotides attached to the nanoparticles, with or without the presence of a third linker oligonucleotide. The hybridized oligonucleotide duplex serves as a substrate for the endonuclease. A detectable change is brought about in the presence of the endonuclease activity. A decrease in the detectable change reflects the reduced levels of endonuclease activities as a result of the effects of endonuclease inhibitors. The present invention also provides kits for screening an endonuclease inhibitor.
A method for screening one or more compounds for its effect on an activity of one or more endonucleases, said method comprising steps of:
A method for screening one or more compounds for their effect on an activity of one or more endonucleases, said method comprising steps of:
A kit for screening for an endonuclease inhibitor comprising:
Dependencies are inferred from the claim text.